Anticuerpo monoclonal anti-CD25 frente a anticuerpos policlonales en el trasplante renal pediátrico
Anticuerpo monoclonal anti-CD25 frente a anticuerpos policlonales en el trasplante renal pediátrico
Los episodios de rechazo agudo del injerto renal, aunque generalmente reversibles, constituyen un factor pronóstico negativo en la supervivencia del injerto a largo plazo. Su prevención es el objetivo a conseguir con la terapia inmunosupresora de inducción, generalizada en el trasplante renal pediátrico. Recientemente se han incorporado a ella nuevos agentes inmunosupresores, entre los que destaca el anticuerpo monoclonal anti-CD25 (basiliximab).
Pediatric kidney transplantation, 32 Ciencias Médicas, Anticuerpos monoclonales, Anticuerpos policlonales, Trasplante renal pediátrico, Baxiliximab, Policlonal antibodies
Pediatric kidney transplantation, 32 Ciencias Médicas, Anticuerpos monoclonales, Anticuerpos policlonales, Trasplante renal pediátrico, Baxiliximab, Policlonal antibodies
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!